Approved Hospital Formulary
Add Formweb to your mobile device
Approved Hospital Formulary
Search results for:
metoprolol
metoprolol
- Formulary Beta-Blocker Formulary
| Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
|---|---|---|---|---|---|---|
| Kapspargo Sprinkle | CAPSULE, EXTENDED RELEASE, ORAL | 25 mg, 50 mg, 100 mg, 200 mg | ||||
| Lopressor | SOLUTION, INJECTABLE | 1 mg/mL | ||||
| ToprOL-XL | TABLET, EXTENDED RELEASE, ORAL | 25 mg, 50 mg, 100 mg, 200 mg | ||||
| Lopressor | TABLET, ORAL | 25 mg, 50 mg, 100 mg |
Last updated: Apr. 15, 2024
All once daily orders for metoprolol (without a salt form specified) will be converted to metoprolol succinate (ToprOL XL) to avoid large once daily doses of the immediate release salt form.
Kapspargo is non-formulary.
For adults who cannot take tablets, automatic interchange to crushed metropolol tartrate tablets. If interchanging long acting succinate once daily to crushed tartrate tablets, BID at the same total dosage. If adult patient can tolerate tablets, convert Kapspargo to metoprolol succinate (ToprOL XL) tablets at same total daily dose.
For pediatrics orders of Kapspargo: if pediatric patient can tolerate tablets and extended release product perferred, extended release metoprolol is available. Contact prescriber prior to changing metoprolol product or dosage.
Reviewed: 22 Jan 19 (Kapspargo), and 27 Aug 19 (Kapspargo and FIRST-Metoprolol)
Updated: October 2020 (FIRST-Metoprolol discontinued)